Related Experiment Video

Updated: Sep 29, 2026

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells
10:21

Proliferation and Differentiation of Murine Myeloid Precursor 32D/G-CSF-R Cells

Published on: February 21, 2018

Hematopoietic growth factors in drug-induced agranulocytosis

K Pavithran1, M Thomas

  • 1Medical College Hospital, Trivandrum.

The Journal of the Association of Physicians of India
|August 21, 2002
PubMed

Insights

Granulocyte macrophage - colony stimulating factor (GM-CSF) effectively treats drug-induced agranulocytosis (DIA), shortening neutropenia. This hematopoietic growth factor reduced patient morbidity and mortality in a clinical study.

Area of Science:

  • Hematology
  • Pharmacology

Background:

  • Drug-induced agranulocytosis (DIA) is a life-threatening condition characterized by a severe reduction in neutrophils.
  • Hematopoietic growth factors are recognized for their therapeutic potential in managing DIA.
  • Systemic infection is a common complication in patients with DIA.

Purpose of the Study:

  • To evaluate the efficacy and safety of granulocyte macrophage - colony stimulating factor (GM-CSF) in treating drug-induced agranulocytosis.
  • To assess the impact of GM-CSF on neutrophil recovery and clinical outcomes in patients with DIA.

Main Methods:

  • A case series of nine patients diagnosed with DIA and treated with GM-CSF at a dose of 300 microg/day.
  • Monitoring of absolute neutrophil count (ANC) to determine the time to recovery.
  • Assessment of clinical outcomes, including systemic infection, morbidity, and mortality.

Main Results:

  • All nine patients received GM-CSF treatment for DIA.
  • The mean time to achieve an absolute neutrophil count of 0.5 x 10(9)/L was three days.
  • One patient died due to multiorgan failure; however, no adverse events were associated with GM-CSF administration.

Conclusions:

  • GM-CSF is a valuable therapeutic agent for drug-induced agranulocytosis.
  • GM-CSF effectively shortens the duration of neutropenia.
  • The use of GM-CSF can reduce morbidity and mortality in patients with DIA.

More Related Videos

Colony-Forming Unit Assay Adapted For Patient-Derived Bone Marrow and Peripheral Blood Mononuclear Cells08:50

Colony-Forming Unit Assay Adapted For Patient-Derived Bone Marrow and Peripheral Blood Mononuclear Cells

Published on: June 26, 2026

Related Concept Videos

Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
Differentiation of Common Myeloid Progenitor Cells01:15

Differentiation of Common Myeloid Progenitor Cells

Common myeloid progenitors (CMPs) are oligopotent cells that can differentiate into granulocytes and macrophages. Granulocytes and macrophages are essential for protecting the body against bacterial, viral, or fungal infections. They migrate from the bone marrow into the circulating blood to reach specific tissue sites where they differentiate and help in immune surveillance. However, they survive only for a few days and must be continuously made available to the organism to maintain a robust...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Hematopoiesis01:21

Hematopoiesis

The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...